Today: 28 June 2026
Visa stock set for Monday as Mexico blocks Prosa deal after the bell
22 February 2026
2 mins read

Visa stock set for Monday as Mexico blocks Prosa deal after the bell

New York, Feb 22, 2026, 13:26 EST — The session ended with the market closed.

  • Visa’s bid to buy a 51% stake in Mexican payments processor Prosa has been nixed by Mexico’s antitrust authority.
  • Visa finished Friday’s session up 0.63%. The regulator’s decision landed after the bell.
  • Traders this week are zeroing in on Visa’s moves in Mexico, plus scanning the broader market for fresh reads on tariffs and inflation.

Mexico’s National Antitrust Commission has blocked Visa’s planned move to acquire 51% of payment processor Prosa, handing down the decision late Friday. The regulator cited potential risks to the financial system, saying the tie-up between the global card network and a big domestic processor—owner of the Carnet card brand—would hurt competition. The ruling could sway the stock when U.S. markets open Monday.

This decision drops on a weekend, which means markets get no time to stagger their reaction—everything hits at Monday’s open. The regulator’s tone is hard to miss. Not only did it claim the deal wipes out a direct competitor, but it flagged Visa’s potential grab of rivals’ transaction data—a level of scrutiny regulators often save for headline cases.

Visa finished Friday at $320.95, gaining 0.63%, after moving in a $317.82 to $322.35 range. News of the Mexico decision emerged after the bell, teeing up potential gap risk for the upcoming session rather than the one just wrapped.

Visa didn’t hold back, labeling the move a blow to both competition and modernization. The company, in a statement, said it’s “disappointed” by the ruling and “carefully reviewing” its next steps, adding that it “will evaluate all available options.” Visa Corporate

Visa barely budged in quiet after-hours action, ticking up just 0.02% to $321.00. These sessions often see light volume and choppy price moves on even minor news.

Traders pushed into riskier assets as the weekend approached. U.S. stocks closed out Friday in positive territory, reacting to the Supreme Court’s decision to overturn President Donald Trump’s global tariffs. Investors also digested Trump’s subsequent move—a short-term 10% tariff—which seemed to provide some relief. “Today is a removal of some uncertainty, and we’re on to the next phase,” said Mike Dickson, Horizon Investments’ head of research and quantitative strategies. Reuters

Macro drivers didn’t quite line up. U.S. economic growth lost momentum in the fourth quarter, Friday’s data showed, while December’s Personal Consumption Expenditures (PCE) price index—the Fed’s preferred inflation metric—picked up speed, complicating the outlook for rate cuts. “Striking down of these tariffs will benefit corporate bottom lines, corporate earnings,” said Tim Ghriskey, senior portfolio strategist at Ingalls & Snyder. Still, he cautioned, policy shifts could rattle markets. Reuters

Payments stocks tracked broader moves Friday, with Mastercard picking up 1.18% to close at $526.41. The gain put it ahead of Visa for the session as traders favored large-cap financial and payments shares.

The setback in Mexico is the kind of regulatory overhang that tends to linger. Should Visa fail to resurrect the Prosa transaction—or if delays mount—it risks complicating ambitions to expand its local processing footprint. That could also draw sharper scrutiny from investors, who may start eyeing other regions where regulators could resist.

Looking ahead, traders are set to scrutinize any updates on Visa’s plans in Mexico, following the company’s announcement that it’s weighing its options. Alongside that, markets are on alert for potential tariff developments and a packed earnings slate, with Nvidia slated to report results this Wednesday, Feb. 25.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Comparing Top XRP ETFs: Fees and Liquidity Matter Most
    June 28, 2026, 2:55 PM EDT. Investors seeking exposure to XRP without using crypto exchanges can choose from five exchange-traded funds (ETFs) that all hold XRP directly. While the underlying asset is identical, key differences among these ETFs include annual fees and liquidity, which impact cost and ease of trading. Franklin Templeton's XRPZ ETF has the lowest fee at 0.19%, making it the most cost-effective for long-term holders. In contrast, Canary's XRPC charges the highest fee at 0.50%. The Bitwise XRP ETF (XRP) leads in size and daily trading volume but is not the cheapest. Selection depends on whether investors prioritize lower fees for holding or liquidity for trading.

Latest articles

Opendoor volume surpasses short interest after Russell 3000 addition

Opendoor shares face Russell 3000 test after 4.5x volume spike

28 June 2026
Opendoor Technologies (NASDAQ:OPEN) surged 448% above average trading volume Friday as its Russell 3000 inclusion took effect, with 171.65 million shares traded—exceeding total short interest and equaling 21% of public float—while the stock closed up 1.63% at $4.37; analysts maintain a Hold consensus and see limited rally potential near current prices.
Coeur Mining shares eye index-driven moves after 8.5% weekly slide

Coeur Mining shares eye index-driven moves after 8.5% weekly slide

28 June 2026
Coeur Mining (NYSE:CDE) ended its first week in the S&P MidCap 400 down 8.5% from June 18, despite Friday’s massive $2.7 billion volume—about 16% of its market cap—highlighting investor caution after recent acquisitions and index changes, as the stock lagged silver-miner peers even with a record quarter expected.
GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines
Previous Story

GE stock price rises as Morgan Stanley starts GE Aerospace; American Airlines keeps CFM LEAP engines

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop